Eulerpool Terminal
The edge that pays for itself.
Current PTC Therapeutics forecasts and price targets in August 2026
Ø Analyst Price Targets
89.01 USD
+20.77 %
Median
88.74 USD
+20.40 %
Max
130.20 USD
Min
60.60 USD
Last Price
73.71 USD
Buy
16
Hold
5
Sell
1
The average target price for PTC Therapeutics is 89.01 USD. (+20.77 % above the current price)
The median price target of PTC Therapeutics is 88.74 USD.
Stock analysts from many renowned investment banks are closely examining the PTC Therapeutics stock. They conclude their professional PTC Therapeutics stock analyses with a clear recommendation for the PTC Therapeutics stock. The forecasts and price targets of professional analysts can be a good indicator of how a stock will perform in the next quarter.
| Buy | Hold | Sell | Ø Analyst Price Targets | |
|---|---|---|---|---|
| 2026-02-01 | 16 | 5 | 1 | 89.01 USD |
| 2026-01-01 | 15 | 6 | 1 | 83.91 USD |
| 2025-12-01 | 16 | 5 | 1 | 83.37 USD |
| 2025-12-01 | 16 | 5 | 1 | 83.37 USD |
| 2025-11-01 | 16 | 6 | 1 | 80.45 USD |
| 2025-11-01 | 16 | 6 | 1 | 69.63 USD |
PTC Therapeutics Stock Forecast 2026: Revenue & Earnings Estimates
Analysts expect the following revenue and earnings for PTC Therapeutics in the coming fiscal years:
| Fiscal year | Revenue | Net Income | Earnings per share |
|---|---|---|---|
| 2026e | 1.18 B USD | 46.00 M USD | 0.57 USD |
| 2027e | 1.34 B USD | 206.00 M USD | 2.55 USD |
| 2028e | 1.59 B USD | 368.00 M USD | 4.56 USD |